Lv1
50 积分 2025-04-18 加入
Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer
3个月前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
4个月前
已完结
Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile janus kinase inhibition
4个月前
已完结
IL-10 targets IRF transcription factors to suppress IFN and inflammatory response genes by epigenetic mechanisms
5个月前
已完结
One-way membrane trafficking of SOS in receptor-triggered Ras activation
7个月前
已完结
FoxM1 insufficiency hyperactivates Ect2–RhoA–mDia1 signaling to drive cancer
7个月前
已完结
Targeted Protein Degradation via Nanoparticles
1年前
已完结
MYC in cancer: from undruggable target to clinical trials
1年前
已完结
Thirty years of NRF2: advances and therapeutic challenges
1年前
已完结
皖公网安备34019202002308
